Related Experiment Video
Updated: Jul 3, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study
Jacopo Venturini1, Mehmet A Baysal1, Abhijit Chakraborty1
1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
DNA repair deficiencies result in genomic instability. Data suggest that genomic instability is associated with response to immuno-oncology (IO) therapies. We analyzed outcomes of patients in the IMPACT2 study by the presence of DNA damage response (DDR) alterations and treatment type. Of 662 patients with ≥1 alterations: 109 (16.5%) had DDR alterations (treated, N = 85) and 553 (83.5%) were DDR wild-type (treated, N = 426). In patients with DDR alterations, absence of liver metastases (p = 0.029) and IO therapy (vs. chemotherapy, p = 0.020; vs. anti-DDR agents, p = 0.048) were independent factors predicting longer overall survival (OS). In the DDR-wild-type cohort, independent factors predicting longer OS were IO therapy (compared with each other treatment group: vs. IO+non-IO combinations, p = 0.003; vs. chemotherapy, p < 0.001; vs. anti-DDR agents, p < 0.001; vs. other targeted therapies, p = 0.006), absence of liver metastases (p < 0.001), and normal albumin (p < 0.001) and lactate dehydrogenase (p = 0.001) levels. Prospective studies are warranted to refine the role of DDR alterations as biomarkers of IO response.
Insights
Genomic instability from DNA damage response (DDR) alterations may predict better outcomes with immuno-oncology (IO) therapy. Absence of liver metastases and IO treatment independently predicted longer survival in patients with DDR alterations.
Area of Science:
- Oncology
- Genetics
- Immunotherapy
Background:
- DNA repair deficiencies lead to genomic instability.
- Genomic instability is linked to patient response to immuno-oncology (IO) therapies.
Purpose of the Study:
- To analyze the outcomes of patients in the IMPACT2 study based on DNA damage response (DDR) alterations and treatment type.
- To determine the role of DDR alterations as biomarkers for IO therapy response.
Main Methods:
- Retrospective analysis of 662 patients from the IMPACT2 study.
- Stratification of patients based on the presence of DDR alterations (DDR altered vs. DDR wild-type).
- Analysis of overall survival (OS) in relation to treatment type (IO, chemotherapy, anti-DDR agents) and clinical factors.
Main Results:
- 109 patients (16.5%) had DDR alterations, and 553 (83.5%) were DDR wild-type.
- In patients with DDR alterations, absence of liver metastases and IO therapy predicted longer OS.
- In DDR wild-type patients, IO therapy, absence of liver metastases, and normal albumin/lactate dehydrogenase levels predicted longer OS.
Conclusions:
- DDR alterations may be associated with improved outcomes in patients receiving IO therapy.
- Absence of liver metastases is a significant predictor of longer OS across both DDR-altered and DDR wild-type cohorts.
- Further prospective studies are needed to confirm the utility of DDR alterations as biomarkers for predicting IO response.
Related Concept Videos
Overview of DNA Repair
Chemically...
Long-patch Base Excision Repair
Overview of DNA Repair
Chemically...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

